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ABSTRACT
Kara L. Geremia M.S., Department of Chemistry, Wright State University, 2015. Computational
Estimation of the pKa’s of Purines and Related Compounds.
The acid dissociation value pKa of a compound provides important information regarding
the neutral and ionic forms of the compound present under different conditions. However, for
many compounds experimental pKa values are not available, and for others the measured values
are sometimes uncertain. Consequently, having a computational means for estimating pKa
values can be of benefit for biochemical, pharmaceutical, polymer, and many other studies.
Purines form a key group of bioactive compounds whose acid/base activities are of considerable
interest. The purine class includes such diverse compounds as the nucleic acid bases adenine and
guanine, the gout-related compound uric acid, the stimulant caffeine, and the leukemia drug 6mercaptopurine. We have developed a computational method for estimating purine pKas using a
quantitative structure property relationship (QSAR) approach. A group of 31 purines and related
compounds was first assembled and then examined using the semi-empirical quantum chemical
method RM1. This was followed by an ab initio analysis based on density functional theory at
the B3LYP/ 6-31+G** level.
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CHAPTER ONE
Introduction: Purines and Related Compounds

1.1 Introduction
Purines and purine-related compounds comprise a large class of biochemically active
compounds with a great diversity of roles. This thesis is devoted to a computational study of
these compounds with an emphasis on the relative stabilities of the tautomers of these
compounds and their acidities.
This chapter is devoted to an introductory description of the uses and biochemical roles
of the compounds examined. Chapter Two explores the tautomerization and implications on
dissociations for six purine related compounds. Chapter Three is an overview of the
tautomerization of five indole related compounds plus caffeine. Chapter Four focuses on the
estimation of the pKa’s of 31 purines and related compounds.
1.2 Historical Background
The purines are N-heterocycles that have an unusual numbering scheme arising from the
fact that the parent compound is treated as a modified pyrimidine ring.1 Most indole-related
compounds such as the indoles, on the other hand, do adhere to the normal numbering pattern for
N-heterocycles.

1

Purine numbering scheme

Indole numbering scheme

Purine-related compounds have been studied since the 1770s when Scheele and
Bergmann isolated uric acid from human urine.1 By the 1880s most naturally occurring purines
had been isolated. This has led to their utilization in many research areas such as
pharmaceuticals,2 industrial applications,3 environmental chemistry,4 and polymer chemistry.5
1.3 Profiles of the Compounds Studied
Thirty-one compounds were compiled for computational analysis. To facilitate a
thorough understanding of these compounds a literature search was performed on each
compound to find its current uses, historical background, and so forth. The pertinent information
obtained for each compound ultimately assists in interpreting the theoretical results.
Adenine, one of the five nucleic acids, is a crucially important compound found in the
human body. It is involved in DNA, RNA, and the energy releasing
compounds adenosine triphosphate (ATP) and nicotinamide adenine
dinucleotide (NAD).6 Due to its ability to phosphorylize other
compounds ATP is central to energy exchange in cells.7 The total
energy released from a phosphodiester bond cleavage on an ATP molecule is -7.3 kcal/mol.8

2

The azaindole series, 4-, 5-, 6-, and 7-azaindole, are
heterocycles that act similarly to pyridine and pyrrole, yet their
range in pKa leads to a broader range of activities and uses.9 In
2014 a 4-azaindole derivative was reported to be a candidate for
tuberculosis treatment.10 Following in the pharmaceutical trend, 5-azaindole and 7-azaindole
were seen as promising Cdc-7 inhibitors for cancer treatment. It can be noted that Cdc-7 is a cell
division cycle-7 kinase that initiates DNA replication during the S-phase.11 Finally, 6-azaindole
has been incorporated in the core of the first small molecule to be used in a treatment of the
Human Immunodeficiency Virus type I.2 7-Azaindole is the most studied of the series. This
compound possesses the unique capability to dimerize due to intermolecular hydrogen bond,
which causes it to preferentially dimerize.12
Benzimidazole is a six membered ring fused to a five membered
ring containing two nitrogens. This compound rose to fame in the mid
twentieth century after it was discovered to be involved in the synthesis

of

vitamin B12. Anthelmintic applications were soon discovered using derivatives of this
compound.13 Presently it is being incorporated into polymeric systems as a bidentate monomer
accompanied by transition metals to be used as the impetus for selfassembling supramolecules.5
Benzimidazoline, the saturated form of benzimidazole, has been
integrated into a select few areas of chemistry. This highly reducing
organic compound that has been noted to react with o-phenyldiamine.14 Benzimidazoline gained
interest due to its ability to undergo exergonic reactions under mild conditions to release
hydrogen that can be used in hydrogen storage. Hydrogen release under conditions described by
3

Schwarz et al.15 provides future hopes for thermodynamically reversible hydrogen
evolution/devolution.
Carbazole is a tricyclic ring that has been applied to
many areas such as environmental, dye production, reagents,
insecticides, and medicinal chemistry.16 Carbazole knowledge
is vital due to the ratio at which it is found in crude oil where its
derivatives comprise the majority of all nitrogen containing compounds. Carbazole can
radicalize easily and become toxic; therefore the removal of residues in oil is a priority.
Researchers have been looking into bacteria which can metabolize this compound. These
bacteria include Pseudomonas resinovorans, Sphingomonas sp. CB3, and various others.17
Caffeine is the mostly widely consumed stimulant in the
world.18 This methylated xanthine acts on the central nervous
system to replace adenosine on the receptors of nerve cells.19
Caffeine is a trimethylated xanthine that is degraded in the liver
to the following three compounds paraxanthine (1,7-dimethyl),
theobromine (3,7-dimethyl), and theophylline (1,3-dimethyl) in decreasing concentrations,
respectively.20 Due to caffeine’s ability to excite and stimulate nerve cells many studies have
tried to correlate its properties to enhanced performances, exceptional creative abilities, and so
forth. A study in the Journal of the American Medical Association has successfully correlated an
increase in caffeine intake to a decrease in Parkinson’s disease in elderly Japanese men.21
Diphenylamine has been known to have antioxidant
properties which have made it prominent in industrial

4

applications. A commercial use for diphenylamine has been to prevent apple scald by dipping
harvested apples into the compound.3 When apples develop the peel disorder the compounds
commonly associated with the lesions and peel pittings are α-farnesene trienols. Treatment with
diphenylamine ameliorates the oxidative damage and allows for the superficial appearances to be
maintained.22
Guanine is a purine nucleobase found in DNA and RNA
that is crucial to the make-up of human life. Guanine is used in
energy transfer within cells. During this process guanine takes
the form of guanine triphosphate, GTP, and follows the same
mechanism as ATP.23 The keto-enol tautomer has been studied extensively going back to the
discoverers of DNA Watson and Crick. The lower energy, more thermodynamically stable keto
tautomer is found frequently, however, the higher energy enol tautomer has been hypothesized to
lead to spontaneous mutagenesis.24 Mismatching of the hydrogen bonding between the
complementary uracil or cytosine can lead to base pair wobble.
Hypoxanthine is a purine derivative that is biologically
important due to its presence in tRNA. Hypoxanthine is a product of
purine and nucleotide degradation. One common pathway that has
been mapped is through fish muscle where ATP dephosphorylates to
AMP so that it becomes deaminated to inosine (the nucleoside of hypoxanthine). This
compound becomes hydrolyzed to hypoxanthine which can be oxidized to xanthine and finally
oxidized to the final product uric acid. Therefore, it has been proposed that the concentration of
hypoxanthine within fish meat can be an indicator of quality.25

5

Indazole is an aromatic heterocycle. This particular species is rarely
found naturally, but has been found in many complex pharmaceutical
agents. Even when it is found in nature it is substituted.26 Indazole’s
framework has been utilized in a variety of biological activities such as estrogen receptors, HIV
protease inhibition, and anti-tumor activity.27 The indazole skeleton has also been documented
in synthetic cannabinoids as psychoactive drugs.28
Indole is a metabolism product of tryptophan. It is produced
naturally by many bacteria, both Gram-positive and Gram-negative,
which apply the compound in intercellular signaling, biofilm
production, and plasmid stability.29 Gut bacteria can produce ample
quantities of indole, which is why indole metabolites can be directly related back to the bacteria
found in the gut.30 Indole has not been found to act as a nitrogen acid in the protonated form,
however indole protonates on the 3(C) position preferentially.31
Indoline is the saturated form of indole. While a wide array of
information can be found on indole the research on indoline is selective.
It was recently shown that N-benzyl tricyclic indoline was used
successfully as an antibiotic for methicillin-resistant Staphylococcus aureus (MRSA).32 Indoline
has been incorporated many times into dye-solar cells as part of the third generation photovoltaic
technology.33
Isatin was first discovered in 1840 by Laurent and
Erdmann.34,35 The compound is found in plants under the genus
Isatis.36 Isatin can also be seen as a component of coal tar and

6

fungi.37,38 There have been many areas of chemistry in which isatin has been utilized.
Remarkably, it has been known for its ability to be used as a dye in hair, as well as its ability to
be used in biological analytical techniques.
The presence of isoguanine in a genome has been studied
extensively due to its ability to form 23 different possible
tautomers. For the five nucleobases in RNA and DNA only certain
tautomers are more dominant in the formation of the natural
polymers.39 The idea of minor tautomers showing up in base pairing has led to the discussion of
mutagenesis and base pair wobble in the genome. Subsequently, Watson-Crick like hydrogen
bonding with isocytosine has been proposed unique complexes and expanded the genomic
alphabet.40
Isoindole is an isomer of indole and far less stable. This results from the compound’s
desire to auto-oxidize and proceed to self-condensation reactions.41
Using the isoindole moiety, many research groups have assessed the
compound’s ability to be utilized in antiproliferative drugs with antitumor activity.42-44 The isoindole skeleton has also been utilized in many dyes, which have been
incorporated into fluorophore and nano-technology.45,46
Oxindole was prepared in 1866 and 1868 by Baeyer.47
The tautomerism of oxindole was explored and it was concluded
that the lactam tautomer was the favorable structure based on

7

spectroscopic studies performed by Ramart and Biquard.48 Since the discovery oxindole has
been patented for use in anti-cancer treatments due to its toxicity levels to cancer cell lines.49
Oxindole is an intermediate compound in the conversion of indole to isatin.
Paraxanthine is a dimethylated xanthine derivative. It
is not a naturally occurring alkaloid, but can be found in
animals as a by-product from caffeine metabolism. Due to
the compound’s ability to act as a central nervous system
stimulant it has been proposed to be found as a metabolite for
cancer cachexia and cancer related anorexia.50 As previously stated, paraxanthine was the
primary product of caffeine degradation as well as caffeine playing a suggestive role in
decreasing the occurrence of Parkinson disease.21,22 Guerrero et al not only agreed with the
findings for caffeine and Parkinson disease, but also mechanistically described paraxanthine as
an inhibitor of neurodegeneration.50
Phthalimide is an imide connected to a six member ring.
This compound has been incorporated in many facets of chemistry
due to its imide functionality. A phthalimide derivative has
recently been used as a drug delivery system for neo-growth
factors in regenerative skin repair polymers. Guadalupe et al
found that phthalimide neovascular factor-1 (CAS#: 10442-95-2) showed promising
characteristics for angiogenic effects.51 The nucleotide ATP is essential in the transduction of
energy in human systems,52 whereas the reduction of ATP concentrations in humans has been
linked to ischemia and various other clinical conditions.53 A polymer that fixed phthalimide to
the backbone was synthesized for colorimetric technology in ATP detection. This phthalimide
8

moiety was essential because the imide mimicked the hydrogen bonding capabilities adenine has
with its complementary base pair, thymine.54
Purine, the core structure for this study, was first
discovered by Emil Fischer.55 The anomalous numbering
scheme of purine follows as if it were a pyrimidine derivative
though it is not.56 Purine has the capability to form four
tautomers. The 7H tautomer has been isolated as the primary
product when purine is in a crystalline form; however, in solution the 7H and 9H tautomers are
in equivalent amounts.57
6-Mercaptopurine is a leukemia treatment discovered by Elion and Hitchings in
1950.58 6-Mercaptopurine is used in combination treatment usually
with methotrexate. Toxicity can occur by cellular uptake and
conversion of guanine nucleotides to thioguanine nucleotides. The
conversion ultimately causes the DNA to become fragile, inhibiting
replication, and causing apoptosis.59 This mechanism may be the
appropriate action for malignant cells, but the attacks happen to healthy cells as well. Be it as it
may, 6-mercaptopurine is still one of the leading treatments in childhood leukemia.
Saccharin, the long time controversial compound, was
discovered in the late 1860s by Constantine Fahlberg60 by
happenstance. This opened the door for artificial sugars to be
used by diabetics because of the zero caloric impact that saccharin
has on the body. Saccharin is excreted from the body and into the

9

waste water systems in its natural form. Subedi et al followed the fate of saccharin in these
systems to show that it can be easily removed; for example, in Albany, New York approximately
1100 g of saccharin are removed from waste-water per day.4
3-Methylindole, more commonly known as skatole, is a
unique compound in that its concentration plays a major role in the
selectivity for its uses. Skatole in high concentrations has been
patented as a malodorant for the United States Military for non-lethal
weaponry.61 Contrary to this, skatole has been known to have a floral scent found in teas62 and
naturally occurring as an odorant in butter.63
Theobromine is the second most common byproduct
of caffeine degradation.20 This 3,7-dimethylxanthine is also
commonly found in cocoa plants, specifically Theobroma
cacao.64 Theobromine has been researched extensively for
its use as an antioxidant in chocolate; however it is now
being considered as a drug release system for a poly(dimethysiloxane) based matrix.65 Many
pharmaceutical drugs have a unique amine or imine functionality thereby allowing theobromine
to be a qualifying candidate.
Theophylline is the least common byproduct of
caffeine degradation.20 It was originally extracted from tea
in 1888.1 Theophylline is commonly used as a
bronchodilator in asthma treatment.66 Recently it has been
thought to have a mechanistic approach in antagonizing a

10

tumor’s necrosis factor alpha and also increase the pro-inflammatory effects of prostaglandin.67
It is because of the multi-faceted functionality of theophylline that a new approach was given to
this old pharmaceutical. It was shown to lower the lipid levels in rats in experimentally induced
hyperlipidemia.68
Uric acid is the final stage in purine metabolism for
humans. It can come from dietary sources or endogenously.
For many years uric acid has been a suspected player in gout,
kidney stone formation and many other ailments that affect
the urinary tract system. The salt form of uric acid, urate, is
released in the human body as a protective response when it experiences hypoxia due to its
antioxidant capabilities.69 Further conclusions were that there was no evolutionary symbiotic
affect for urate’s antioxidant capabilities, where as it developed as a biochemical coincidence.70
Unusually high levels of uric acid in the blood has been linked to many diseases such as
hyperuricemia, cardiovascular disease, and Lesch-Nyan disease.71 On the contrary, low levels of
uric acid has been linked to diabetes mellitus, liver cirrhosis, and xanthinuria.72
9-Methyluric acid has been used in many research
areas. 9-Methyluric acid has been noted to be less soluble
in aqueous solution than uric acid. This decreases in
solutions is a mode for forming urinary calculi. Various
analytical techniques have been proposed for the study of
these structures including HPLC with UV/VIS spectrophotometry.73 Uric acid derivatives have
been known to assist in peroxynitrite radical elimination as endogenous scavengers. Heightened
peroxynitrite concentrations have led to an increase in pathogenesis of multiple sclerosis and
11

experimental allergic encephalomyelitis.74 An immunological proposal has been made to
increase the amount of uric acid and uric acid derivatives in a system to alleviate multiple
sclerosis symptoms.75
Xanthine is the second to last product in human purine
metabolism. The enzyme xanthine oxidase converts the carbon at
the 8 position on the five membered ring from an sp2 hybridized
carbon to a ketone.

Xanthine was originally discovered in 1902,

where it was thought to be an aldehyde reductase.76 The xanthine
oxidase protein is the target site for many pharmaceutical agents that treat gout and
hyperuricemia.77 Xanthine oxidase has a molybdenum center and this center is conventionally
established to be the location of the binding of xanthine.78
Methylated purine derivatives have been proposed to
play a large part in biological chemistry. 9-Methylxanthine is
a naturally occurring purine that can be coordinated with
platinum complexes to facilitate in cancer treatment and
tumor identification.79 N-substituted purine derivatives were
shown to have a substantial inhibitory effect on cyclin-dependent kinases which are invariably
used in all phases of the cell division cycle.80
It became apparent during the literature search that purine and purine related compounds
have a unique capability to tautomerize. A tautomer is a constitutional isomer in which the
compound retains the same number of atoms, however the connectivity is different. Specifically
for the N-heterocyclic systems studied, prototropic tautomerization was displayed not only on the
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aromatic nitrogens, but the exo amines, mercapto group, and carbonyl groups. Furthermore, the
formation of tautomers is not limited to the neutral species but extends to ionized forms. In
conclusion if one knows the probable tautomeric forms of the neutral, cationic, and anionic
species it is inherent to knowing the structure the compound takes in different environments, i.e.
pKa.
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CHAPTER TWO
Computational Analysis of Cationic, Neutral, and Anionic Purine Tautomers

2.1 Abstract:
The tautomers for neutral, cationic, and anionic purine, 6-mercaptopurine, adenine,
guanine, hypoxanthine, and xanthine were examined using quantum chemical B3LYP/6-31+G**
calculations both in vacuum and with the SM8 solvent model to estimate the most stable forms
present. Keto-enol, amine-imine, and thione-thiol tautomerisms were investigated in the neutral
forms. The corresponding cationic and anionic species were examined.
2.2 Introduction:
The tautomeric states of purines and related compounds have been discussed extensively
for decades.1-9 In most of the tautomeric studies an important feature was the nature of not only
the neutral species, but also of the protonated and deprotonated forms of the compounds.10 The
importance of understanding tautomer behavior is apparent in DNA structure, since when a
higher energy, less stable tautomer bonds to a complementary base the resulting mismatch of the
base pairs can lead to mutagenesis.
The goal of the present report is to examine the cationic, anionic, and neutral tautomers
of six purines and related compounds—purine, hypoxanthine, 6-mercaptopurine, xanthine,
adenine, and guanine—in order to establish the groundwork for a later theoretical pKa study.
While 6-mercaptopurine is not a naturally occurring purine derivative it is used commonly in the
treatment of childhood leukemia,11 and thus is an important medicinal compound. Although
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many groups have examined specific tautomers of purines, we are not aware of any
comprehensive, detailed study being presented.
A secondary goal of this report was to understand the relative populations of the different
tautomers of these compounds in aqueous solution. There are two main factors that affect the
populations: the intrinsic stability displayed in the vacuum energy of each tautomer and the
adjustments to these energies resulting from the compound’s placement within a solvent, i.e. the
solvation energies. The solvation energy is determined by the interaction of the compound with
the solvent via the prevailing intermolecular forces. These forces consist of hydrogen bonding,
London dispersion forces, electrostatic forces, etc. The solvation energies are important to
understand because they strongly affect tautomer stabilities in different media. One expects
greater solvation energies in water to occur for more polar species. An illustration of this can be
seen in Figure 2.1

Figure 2.1 An illustration of the intrinsic energies and the adjustment to the energies as a result
from being placed in a solvent model.
We note that the global dipole moment of a compound can be viewed as a gross measure
of the compound’s polarity, but a more relevant measure for aqueous solvation would involve
the microscale point-to-point charge heterogeneity. It should also be noted that the solvation
21

energies are generally larger in magnitude for compounds with more electronegative atoms, and
even more so for species with ionic charges.
Tautomers of a compound are constitutional isomers such that the individual compounds
consist of the same atoms; but with shifts in the hydrogen positions. The tautomerism of the
compounds mentioned is of great importance because it is expected that the more stable
tautomeric forms will play the greatest roles in physiological systems. The Boltzmann
distribution equation was utilized to calculate the population ratios one would expect to find for
the various tautomers.
2.3 Computational Methods:
Theoretical calculations were performed on each compound using the Spartan’10
computational package (Wavefunction, Inc., Irvine, CA). Initial geometry optimizations were
performed using the semi-empirical RM1 method.12 This was followed by optimization using
density functional theory with the B3LYP functional13,14 and the 6-31+G** basis set. Each
compound was optimized first under vacuum conditions and then re-optimized with the SM815
water solvent model. All reasonably plausible tautomers were examined using the
aforementioned calculations. Once the most stable neutral tautomer was established, related
cationic tautomers were constructed by appropriate additions of protons. The neutral form was
also employed to form anionic tautomers by removing protons from relevant positions.
As a reminder the purine numbering system is shown below:
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2.4 Results and Discussion:
2.4.1 Purine:
Purine is an ubiquitous compound in chemistry. Experimentalists have examined this
compound for its acid-base behavior because it is the main skeleton for many compounds found
in biological systems, polymer science, medicinal chemistry, and environmental chemistry.
Experimentally, the two tautomeric forms that are of most concern for purine are the 7H-P and
9H-P isomers. The naming chosen for the compounds indicates the atoms that hold the protons.
Many authors agree that, in solution, purine will exist in roughly equal concentrations of these
two tautomers. However, in a crystalline form the 7H-P tautomer is the only one present.5,6

Figure 2.2. Four possible neutral tautomers of purine with energy differences calculated in
vacuum.
In contrast to the experimental observations in solution, the present B3LYP/631+G**/SM8 calculations yielded the tautomer distributions as shown in Table 2.1 and Figure
2.2. The contrast is that the calculations indicate a greater difference in stability of the 9H-P and
7H-P tautomers, both in vacuum and in solution. The vacuum calculations place the 9H-P
tautomer roughly 16 kJ mol-1 below the 7H-P tautomer.

23

In contrast, the aqueous solution (SM8) results place the 7H-P tautomer roughly 16 kJ
mol-1 below the 9H-P tautomer as a result of its greater solvation energy. The vacuum
calculations above coincide with a more uniform electron density map as shown in Figure 2.3.
The larger solvation energy of the 7H-P tautomer comes as a result of the more heterogeneous
charge distribution in this tautomer, which leads it to interact more strongly with the aqueous
solvent.

Figure 2.3 Molecular electrostatic potential maps of the 9H-P and 7H-P tautomers of purine.
The present calculations for purine were optimized using density functional theory with a
diffuse function placed on the heavy atoms only and polarization functions on both light and
heavy atoms. Earlier theoretical calculations7 were performed on purine at lower computational
levels. Nowak and group used Hartree-Fock calculations, HF/6-31(d,p), where the vacuum ab
initio calculations favored the 9H-P tautomer by approximately 16 kJ mol-1 over the next stable
7H-P tautomer. It was argued that in solution the 7H-P should be more stable. The present
calculations reach the same conclusion as shown in Table 2.1.
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Table 2.1. Relative energies and solvation energies of the neutral, cationic, and anionic
tautomers for purine.
Purine – Neutral Tautomers
Compound

ΔEVAC (kJ mol-1)

ESOLV. (kJ mol-1)

ΔEH2O (kJ mol-1)

9H-P

0.00

-48.7

16.6

7H-P

16.2

-82.1

0.00

3H-P

41.2

-64.5

42.2

1H-P

54.9

-92.3

28.1

Purine Cation Tautomers
Compound Vacuum

ΔEVAC (kJ mol-1)

ESOL. (kJ mol-1)

Compound Water

ΔEH2O (kJ mol-1)

1,9(H)-P+

0.00

-271.

1,9(H)-P+

0.00

3,7(H)-P+

13.3

-269.

1,7(H)-P+

0.48

1,7(H)-P+

21.0

-292.

7,9(H)-P+

3.47

7,9(H)-P+

28.0

-296.

3,7(H)-P+

16.2

3,9(H)-P+

46.5

-282.

3,9(H)-P+

35.3

9(H2)-P+

208.

-317.

7(H2)-P+

156.

7(H2)-P+

227.

-342.

9(H2)-P+

164.

P-

0.00

Purine Anion*
P-

0.00

----

As shown above, depending on the environment, neutral purine should exist
predominately as one stable tautomer, whereas each neutral tautomer will have its own cationic
tautomer. The results are displayed in Table 2.1. It should be noted the most stable cationic
tautomer for both neutral species places the protonation site on the pyrimidine ring (1,7(H)-P+
and 1,9(H)-P+). As a result of tautomeric equilibrium, the 1,9(H)-P+ form should prevail in
vacuum and in aqueous solution.
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Figure 2.4. Cationic tautomers with decreasing stabilizations as found in vacuum.
Based on the relative energy differences, a major conclusion can be made. It should be
recognized that protonated imines are more energetically stable, by far, than protonated
secondary amines. Whereas in both cases the nitrogens have two lone electrons and are sp2
hybridized the orientation of the electrons are crucial to cationic stabilities. The imine holds the
lone electrons in an sp2 orbital. These electrons do not participate in the resonance and
aromaticity of the neutral species. The amine holds the lone pair electrons perpendicular to the
compound in a 2pz orbital. Conversely, the electrons in this orbital can participate in resonance
and aromaticity of the neutral species. Interruption of any electrons involved in a conjugated
system will result in a much less stable ionized species. This is why the relative energy of 9(H2)+
is so great.
The anionic purine tautomer relative energies are displayed in Table 2.1. It was
previously mentioned that one stable neutral tautomer will exist depending on the environment;
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likewise each environment will have its own anionic tautomers. The following figure shows the
dissociation pattern for the stable neutralanion purine tautomer in vacuum.

Figure 2.5. The deprotonation of the favored tautomer (9H-P) in vacuum to its anionic form.
2.4.2

Hypoxanthine:

Hypoxanthine is the third to final metabolic intermediate in purine metabolism for
humans and higher primates. This nucleobase can also be formed from the deamination of
adenine8 As shown in Figure 2.6, hypoxanthine can be represented by eight tautomers, with four
keto and four enol forms. The solvent energies for the eight different tautomers are listed in
Table 2.2.
In both vacuum and the aqueous solvent, there was only a small energy difference of 1.30
kJ mol-1 between 1,9(H)-HX and 1,7(H)-HX, with 1,9(H)-HX found to be more stable in
solution. This indicates that both low energy tautomers should be present as a mixture. The
small energy difference between the stable tautomers is lower than RT (~2.48 kJ mol-1). Also
supporting this conclusion are various NMR studies in different solvents at varying temperatures
that showed a nearly 1:1 ratio of the two tautomers.16,17 However, the tautomeric populations in
aqueous solutions still remain undetermined.16,18,19 As expected from previous studies,5,6,11 the
enol tautomers were found, in general, to lie higher in energy than the keto tautomers.
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Table 2.2. Relative energies and solvation energies of the neutral, cationic, and anionic
tautomers for hypoxanthine.
Hypoxanthine -Neutral
Compound

ΔEVAC (kJ mol-1)

ESOLV. (kJ mol-1)

ΔEH2O (kJ mol-1)

1,7(H)-HX

0.00

-77.7

1.30

1,9(H)-HX

3.42

-82.3

0.00

3,7(H)-HX

31.7

-101.

10.1

3,9(H)-HX

88.5

-135.

32.0

Hypoxanthine Cations
1,7,9(H)-HX+

0.00

-302.

0.00

1,3,9(H)-HX+

65.0

-332.

35.0

1,1,9(H)-HX+

194.

-311.

185.

1,9,9(H)-HX+

207.

-340.

169.

Hypoxanthine Anions
1H-HX-

0.00

-306.

0.00

9H-HX-

27.3

-331.

35.0
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Figure 2.6. Hypoxanthine tautomers and their relative energies in vacuum.
The relative energies for the cationic tautomers of hypoxanthine are listed in Table 2.2.
Since the neutral form of hypoxanthine exists as two statistically probable tautomers in solution,
it is assumed each of these would be capable of ionizing into a cationic form. However, both of
the two dominant neutral tautomers lead to the same cationic form. The cationic tautomers as
found in vacuum are depicted in Figure 2.7.

Figure 2.7. Cationic tautomers resulting from the 1,9(H)-HX neutral tautomer in vacuum.
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Gogia et al.9 viewed the ionization sites of hypoxanthine using surface enhanced raman
spectroscopy (SERS) and theoretical calculations to correlate the experimental findings.
Accordingly, hypoxanthine was found to exist as one major tautomeric form, where the sp2
hybridized imine in the imidazole ring holds the positive charge from the cation. The
experimental results were the same as those calculated in Table 2.2.
The anionic tautomers for hypoxanthine exist in two probable forms. The relative
energies are displayed in Table 2.2. As before, since there are two stable neutral tautomers in
solution one should expect two find four unique anionic tautomers. This is due to the low
energies of all solvent-stabilized anionic tautomers. Experimentally, through the use of NMR
spectroscopy, more than one tautomer has been found in solution.16,20 It should be noted that this
is not expected in vacuum due to the calculated relative energy difference being 27.3 kJ mol-1.

Figure 2.8. Relative energies for deprotonation of the two neutral hypoxanthine tautomers, a)
1,9-hypoxanthine and b) 1,7-hypoxanthine, to their anionic forms as found in a water solvent.
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2.4.3

6-Mercaptopurine:

An important purine derivative, 6-mercaptopurine (MP) is not found naturally in
biological systems, but has been utilized as a chemotherapy agent since the mid 20th century. Its
structure is similar to hypoxanthine, but with the carbonyl group replaced by a thione group.
Table 2.3. Relative energies and solvation energies of the neutral, cationic, and anionic
tautomers for 6-mercaptopurine.
6-Mercaptopurine -Neutral
Compound

ΔEVAC (kJ mol-1)

ESOLV. (kJ mol-1)

ΔEH2O (kJ mol-1)

1,7(H)-MP

0.00

-71.3

0.00

1,9(H)-MP

13.1

-75.3

9.15

3,7(H)-MP

36.4

-41.9

26.0

3,9(H)-MP

103.

-118.

57.0

6-Mercaptopurine Cations
1,7,9(H)-MP+

0.00

-291.

0.00

1,3,7(H)-MP+

16.6

-295.

13.3

1,7,7(H)-MP+

200.

-326.

165.

1,1,7(H)-MP+

204.

-316.

180.

6-Mercaptopurine Anions
7H-MP-

0.00

-280.

2.74

1H-MP

1.92

-285.

0.00

In analogy to the keto-enol equilibrium, the thione-thiol equilibrium for the neutral
molecule appears to favor the thione forms. As seen in Table 2.3 and Figure 2.9, 1,7(H)-MP is
theoretically determined to be the most stable. The tautomerism of neutral MP has also been
examined through NMR spectroscopy, which showed that the same neutral tautomer was
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favored.16,17 This was surprising because of the interruption of resonance from the thione
functionality.

Figure 2.9. Thione-thiol tautomers of 6-mercaptopurine as calculated in vacuum.
The extremely high energy calculated for the 3,9(H)-MP tautomer in both vacuum and
solution warrants some additional discussion. In contrast to the thiol tautomers one might expect
this thione tautomer to have a lower energy, but it does not. The high energy of this tautomer
has several origins. First, the two close-lying NH groups on the meta secondary amines on the
lower side in 3,9(H)-MP increase repulsive electrostatic interactions in this compound. This is
reflected in the longer NH bond lengths in 3,9(H)-MP as shown in Figure 2.10. Second,
additional repulsive interactions occur between the two top imine nitrogen lone pair electrons
and the lone pairs on the sulfur atom.
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Figure 2.10. Illustrations showing bond lengths for the favored thione tautomer 1,7(H)-MP and
the high-energy 3,9(H)-MP as found using the water solvent model.
The relative cationic tautomer energies for 6-mercaptopurine are listed in Table 2.3.
Protonated imines are again shown to be more stable than the corresponding protonated amines.
This observation holds true for all nitrogen acids shown here. Between the two possible imine
sites to protonate the imidizole ring is more probable because the ring does not lose its
aromaticity upon the protonation. While these compounds do not have resonance through both
rings, the most stable cationic tautomer can be explained by the imidazole ring not losing
resonance upon protonation. The two unfavored cationic tautomers can be explained through
basicity. 1,7,7(H)-MP+ would result in a non-aromatic imidazole ring while 1,1,7(H)-MP+ is less
basic because of resonance with the thione group.
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Figure 2.11. Cationic tautomers from the 1,7(H)-MP neutral tautomer as found in vacuum.
The relative energies for the anionic tautomers of 6-mercaptopurine can be seen in Table
2.3. The compound possesses two different dissociations sites leading to the formation of two
anionic tautomers. Both of the anionic tautomers are predicted to exist in appreciable amounts
because of the small energy difference calculated between them in both vacuum and solution.

Figure 2.12. Anionic tautomers for 6-mercaptopurine as found in vacuum.
There have, in the past, been conflicting experimental results regarding the evidence for
stable anionic tautomers. Lichtenberg19 and colleagues used NMR to reveal NH(1) to be more
acidic than NH(7), allowing for this to be the predominant anionic form. On the other hand,
Pazderski21 and colleagues used crystalline mercaptopurine in alkaline solution to evaluate the
34

anionic tautomers using 15N NMR spectroscopy. They observed the more prominent anionic
tautomer to be 7H-MP-. It is our conclusion that the solvent used in the NMR studies affects the
tautomeric populations, especially true when comparing polar protic and aprotic solvents.
2.4.4

Xanthine:

Xanthine exists as a neutral diketo-purine derivative that participates in many
biochemical processes. It is also formed through the deamination of guanine. As previously
discussed, enolic tautomers are not normally stable species; they were therefore not included in
subsequent energy calculations. Figure 2.13 illustrates the two lowest energy keto tautomers for
xanthine in vacuum. It can be seen that even with the two lowest lying tautomers, only one
would be found in solution or in vacuum. The stability for 1,3,7(H)-X over 1,3,9(H)-X lies in
electronic factors. The NH(9) hydrogen would interact repulsively with the NH(3) hydrogen.
However, the 1,3,7(H)-X tautomer would be electronically stabilized by the lone pairs on the
nearby oxygen and the proton on the 7-position.

Figure 2.13. The two lowest-energy keto tautomers of xanthine calculated in vacuum.
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Table 2.4. Relative energies and solvation energies of the neutral, cationic, and anionic
tautomers for xanthine.
Xanthine -Neutral
Compound

ΔEVAC (kJ mol-1)

ESOLV. (kJ mol-1)

ΔEH2O (kJ mol-1)

1,3,7(H)-X

0.00

-75.2

0.00

1,3,9(H)-X

39.0

-94.2

20.0

Xanthine Cations
1,3,7,9(H)-X+

0.00

-337.

0.00

1,1,3,7(H)-X+

109.

-294.

152.

1,3,3,7(H)-X+

114.

-308.

143.

1,3,7,7(H)-X+

170.

-360.

147.

Xanthine Anions
1,3(H)-X-

0.00

-273.

0.00

1,7(H)-X-

40.8

-313.

1.03

3,7(H)-X-

69.9

-338.

5.70

The cationic tautomers for xanthine exist in four probable forms, where the most
probable protonation site exists on the imidazole ring. The relative energies are listed in Table
2.4.
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Figure 2.14. Cationic tautomers for xanthine from the vacuum calculations.
Examination of the cationic tautomers for xanthine exposes just how stabilizing electrons
that participate in aromaticity can be. There is only one sp2 hybridized imine and it can be
reasoned one plausible cationic tautomer will exist where the imine becomes protonated. The
vacuum and solvent model calculations reveal the same trend.

Figure 2.15. Anionic tautomers for xanthine found in vacuum.
There are three probable forms for anionic xanthine. The relative energies are listed in
Table 2.4. In vacuum and aqueous solution the most stable anionic tautomer has the dissociation
site on the imidazole ring. However, based on experimental results from several groups the
actual dissociation site on xanthine remains a mystery. Based on the two electron-withdrawing
carbonyl groups one would assume the NH(1) position to dissociate more readily. Cavalieri et
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al.22 initially studied the tautomers of anionic xanthine using ultraviolet spectroscopy in 1953 to
place the dissociation at the NH(3) position. Correlating to that work, Pfeiderer23 et al used the
same instrumentation and found the same dissociation product in 1961. Contrary to this,
Bergmann and colleagues used NMR and UV-Vis in 1970 to find similar results to ours. Lastly,
in 2009 Gogia et al.9 used ultraviolet resonance Raman to uncover the same trend as Cavalieri
and Pfeiderer. Based on this evidence, and the relative energies in solution listed in Table 2.4,
there is a distinct possibility that all of these tautomers exist in solution. The intrinsic properties
of the compound are theoretically explained through the vacuum energies, where we propose the
1,3(H)-X- tautomer to be the more stable product. As mentioned before, the natural charges on
the nitrogen atoms can yield insight to the stabilization of tautomers. These are highlighted in
Figure 2.16 where the values in red are the natural charges on the nitrogen atoms. Since the
NH(7) position has the more positive charge it can be assumed that the bond strength (nitrogenhydrogen) will be weaker.

Figure 2.16. Natural charges for the stable neutral tautomer in solution with the possible
dissociation sites highlighted in red.
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2.4.5

Adenine:

Adenine and guanine are the two purine nucleobases incorporated into DNA and RNA.
Watson, Crick, and others proposed that if the nucleobases did not exist in their most
energetically favorable forms the genomic alphabet would drastically expand.24 Adenine has the
potential for prototropic shifts to transform its exo primary amine into an imine. The six
tautomeric arrangements for adenine are shown in Figure 2.17.

Figure 2.17. Tautomer energies of adenine determined in vacuum.

It is clear that the imine tautomers fall higher in energy than the amine tautomers and
therefore are less likely to be important. While the existence of the higher energy tautomers is
theoretically possible the likelihood for these tautomers to appear in DNA has been debated.
There has yet to be one dominant conclusion on the importance of the higher-energy tautomeric
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forms. The two contending arguments for their formation lie between a proton shift via quantum
tunneling or a classical barrier hop.25 On the rare occasions that the less favored tautomer might
exist it would lead to a spontaneous point mutation and a coding error. One can also hypothesize
that a person’s environment might impact the likelihood of having a mutation occur via either
route. Future research could therefore include a focus on the environmental route in which the
mutagenic tautomers occur as opposed to a mechanistic route. This may yield greater insight to
medical and clinical implications.
Table 2.5. Relative energies and solvation energies of the neutral, cationic, and anionic
tautomers for adenine.
Adenine –Neutral
Compound

ΔEVAC (kJ mol-1)

ESOLV. (kJ mol-1)

ΔEH2O (kJ mol-1)

9H-A

0.00

-63.0

0.00

3H-A

34.1

-80.6

16.5

7H-A

37.2

-85.5

14.7

1H-A

80.2

-115.

28.0

Adenine Cations
1,9(H)-A+

0.00

-267.

0.00

7,9(H)-A+

6.36

-297.

4.06

3,9(H)-A+

34.7

-268.

9.27

9H2-A+

192.

-338.

120.

Adenine Anions
A-

0.00

-295.

0.00

10H-A-

79.1

-310.

64.5
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It is essential to understand the ionized tautomers of biologically relevant compounds
because adenine forms hydrogen bonds to thymine via the N1 position and the primary amine. If
this position is occupied, either by being exposed to an acidic condition (pH< 3) or through
oxidation, bonding mismatch is likely to cause mutations.

Figure 2.18. Cationic tautomers with decreasing stabilities found in vacuum.
Adenine has the capability to form two anionic tautomers and the relative energies for
these are listed in Table 2.5. The predominant form results from the dissociation of the NH(9)
proton. A rare anionic tautomer could result in the dissociation from the exo amine.

Figure 2.19. Two anionic tautomers for adenine with relative energies found in vacuum.
Quantum chemical descriptors are used to explain the theoretical findings. The natural
charges on the 9H and exo amine are -0.581 and -0.826, respectively. It should be noted the
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charge on an atom is not an actual property that can be determined, because electronic
contributions cannot be treated as point charges, unlike a nucleus. It has been found in the past
that the natural charge is a valid descriptor for the compounds examined. The bond lengths for
the nitrogen-hydrogen bonds for the 9H and exo amine are 1.023 and 1.015, respectively as well.
In conclusion, the lower negative charge and shorter bond length for the exo primary amine
makes dissociation at that position unlikely.
2.4.6

Guanine:

Guanine is interesting when examining possible tautomeric arrangements. Guanine
exists in its neutral form as an amine-keto tautomer. As described for adenine the amine-imine
tautomer equilibrium generally finds the primary amine form to be more stable, in the same way
as keto-enol tautomerization favors the keto form. Since guanine has both moieties, one might
anticipate that the energetically favorable form would be an amine-keto tautomer. There should
be four neutral tautomers for guanine, as depicted in Figure 2.20.

Figure 2.20. Neutral keto-amine tautomers of guanine as determined in vacuum.
Guanine is one of the unique compounds where the most stable tautomer is not the same
in vacuum and in solution; the relative energies are listed in Table 2.6. The results suggest that a
mixture of 1,9(H)-G and 1,7(H)-G would exist in both vacuum and aqueous solution, with the

42

predominant form depending on the state. That is to say 1,7(H)-G will be the predominant form
in vacuum while 1,9(H)-G is predominant in solution.
Table 2.6. Relative energies and solvation energies of the neutral, cationic, and anionic
tautomers for guanine
Guanine – Neutral Tautomers
Compound

ΔEVAC (kJ mol-1)

ESOLV. (kJ mol-1)

ΔEH2O (kJ mol-1)

1,7(H)-G

0.00

-96.5.

4.05

1,9(H)-G

2.34

-103.

0.00

3,7(H)-G

29.6

-122.

8.20

3,9(H)-G

84.2

-157.

28.1

Guanine Cation Tautomers
Compound
Vacuum

ΔEVAC (kJ mol-1)

ESOLV (kJ mol-1)

Compound Water

ΔEH2O (kJ mol-1)

1,7,9(H)-G+

0.00

-299.

1,7,9(H)-G+

0.00

1,3,7(H)-G+

22.1

-305.

1,3,7(H)-G+

16.1

1,3,9(H)-G+

75.4

-337.

1,3,9(H)-G+

37.4

1,1,9(H)-G+

169.

----

1,7,7(H)-G+

156.

1,1,9(H)-G+

189.

-332.

1,9,9(H)-G+

158.

1,1,7(H)-G+

194.

-319.

1,1,7(H)-G+

174

1,9,9(H)-G+

198.

-339.

1,1,9(H)-G+

----

Guanine Anion Tautomers
7H-G-

0.00

-336.

9H-G-

0.00

1H-G-

2.18

-335.

7H-G-

2.03

9H-G-

12.2

-351.

1H-G-

6.11

Guanine is the most ionizable of the nucleobases.26 As stated above the cationic tautomer
stabilities are important to understand because of the hydrogen bonding arrangements the purine
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nucleobases form with pyrimidines. Upon protonation, the stable cationic tautomers in aqueous
solution and vacuum are resonance forms of each other. This implies that regardless of the
medium for the protonated form, only one probable form will exist.

Figure 2.21. Cationic tautomers of guanine found in vacuum.
It can be seen that the tendency for the proton to attack the imine on the imidazolic ring
takes precedence. As shown in Figure 2.20 there is an electron-donating amino group ortho to an
sp2 hybridized imine, the electron withdrawing carbonyl group is highly effective at decreasing
the electron density on the imine nitrogen atom. The end result is protonation on the imine
nitrogen atom of the imidazole ring.
Guanine can form three anionic tautomers of interest for the current research and their
relative energies are listed in Table 2.6. In solution both neutral tautomers contribute to the
anionic tautomer populations. Conversely, in vacuum, any anionic tautomer should be formed
from the predominant neutral tautomer.
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Figure 2.22. Three anionic tautomers that should be probable in solution for guanine as found in
vacuum.
In vacuum and solution the dissociation site takes place on the six-member ring. This can
be rationalized due to the electron withdrawing carbonyl substituent and electron donating
amine. The amine pushed electronic density through the pi system to the N(3) position. This
causes the NH(1) site to be more electropositive. Also, the charge build up around the N(1)
position site can be distributed through the different donor/acceptor groups and peptide bond
resonance. If the charge was placed on the imidazolic ring it would not be distributed as readily.
2.5 Conclusion:
The six compounds studied indicate the necessity to fully understand the tautomer
distributions and how these distributions might affect the experimental biochemical processes.
Once the tautomer distributions are fully understood an understanding of how the pKa’s vary
may become clearer.
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CHAPTER THREE
Computational Analysis of Tautomers for Indole and Related Compounds

3.1 Abstract:
This report deals with the tautomer stabilities of the cationic, neutral, and anionic forms
of five indoles and related compounds—indole, isoindole, indazole, benzimidazole, and 7azaindole—plus caffeine. To evaluate the most stable neutral tautomers of each compound
quantum chemical calculations were first compared with literature data. From these results the
stability of the corresponding cationic forms was explored. All of the compounds possess only
one potential site for deprotonation, leading to the anionic forms.
3.2 Introduction:
Indoles and related compounds have a wide range of uses in forensic chemistry,1 polymer
science,2 pharmaceuticals,3 as well as playing a key role in biochemical signaling for bacteria.4
These compounds display a variety of tautomeric forms in aqueous solution. This report focuses
on the tautomerism of indole, isoindole, indazole, benzimidazole, 7-azaindole, and caffeine, as
studied through quantum chemical calculations in vacuum and aqueous solution.
Our interest ultimately lies in the populations of the different tautomers of a compound in
aqueous solution. In addition to tautomeric forms a compound can exist in different charge
states. Each of the charge states, neutral, cationic, and anionic, can display its own set of
tautomeric forms. Two factors determine the relative proportions of the tautomeric forms: the
intrinsic stabilities, as exhibited by the vacuum energies of each tautomer, and the adjustment to
this energy resulting from the compound’s placement within a solvent, i.e. the solvation energy.
This latter term is determined by the prevailing intermolecular forces, such as hydrogen bonding,
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London dispersion forces, and electrostatic forces. It should be noted that ionic species have
considerably larger solvation energies than neutral species due to their stronger electrostatic
interactions.
3.3 Computational Methods:
Five compounds were examined for their energetic stabilities using Spartan ’10
(Wavefunction, Inc. Irvine, CA). Indole, isoindole, indazole, benzimidazole, and caffeine were
optimized using a semi-empirical method, RM1.5 The geometry was further optimized using
density functional theory at the level B3LYP/6-31+G(d,p).6,7 Each compound was optimized in
vacuum followed by an application of a water solvent model, SM8.8 All neutral tautomers were
placed under the aforementioned parameters. Upon completion, the tautomers were made into
cations and anions. The dissociation of a proton from a cationneutral indicates pKa1 and
neutralanion indicates pKa2. The numbering scheme for indole is pictured below.

3.4 Results and Discussion:

3.4.1

Indole
3.4.1a. Neutral tautomers:
Indole is a stable compound due to its aromaticity. Its stabilization energy has been

estimated to be only slightly less than that of naphthalene.9 The three neutral tautomers of
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indole, 1H-I, 3C-I, and 2C-I, were examined (see Figure 3.1) and their relative energies are listed
in Table 3.1. Based on the calculations performed it would be expected to find only one
dominant tautomer in vacuum or in solution, which can be explained through aromaticity.
Tautomer 1H-I is fully conjugated, follows Hückel’s 4n+2 rule, and has sp2 hybridization of each
atom in the system. Tautomers 3C-I and 2C-I have 8π electrons, non-continuous conjugation,
and one carbon atom with sp3 hybridization.

Figure 3.1. Neutral tautomers for indole as found in vacuum.
3.4.1b. Cationic tautomers
Much like pyrrole, indole acts as a weak base, where the protonation at the nitrogen atom
of 1H-I would result in the loss of aromaticity as a result of the change in hybridization from sp2
to sp3.10 Accordingly, the protonation occurs at the C3 position. The relative energies listed in
Table 3.1 and the structures shown in Figure 3.2 depict how impactful a change in hybridization
can be.
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Table 3.1. Relative energies and solvation energies of the neutral and cationic tautomers for
indole.
Compound

ΔEvac (kJ mol-1)

Esolv (kJ mol-1)

ΔEH2O (kJ mol-1)

Indole –Neutral
1H-I

0.00

-21.3

0.00

3C-I

40.7

-25.5

36.6

2C-I

122.

-35.7

107.

Indole Cations
3C-I+

0.00

-264.

0.00

2C-I+

21.1

-227.

58.0

1H-I+

59.8

-248.

75.4

Figure 3.2. Cationic tautomers for indole as found in vacuum.
Alata and colleagues11 used electron spectroscopy of cold protonated indole in the gas
phase to experimentally produce the same trend in tautomer stability. Although we are not the
first group to indicate that protonated indole behaves as a carbon acid, it is our intention to
provide a clear-cut, unambiguous depiction of the pathway for protonation and deprotonation of
indole (see Figure 3.3).
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Figure 3.3. The deprotonation scheme to the neutral tautomer of indole.
As discussed previously, multiple factors influence tautomer stability, one of which is
hybridization. More compelling evidence for the scheme depicted in Figure 3.3 is that the
hybridization of N(1) remains sp2. If the scheme were to allow for the deprotonation of 1HI+1H-I the nitrogen would go from sp3 to sp2. Adding to this, the indole compound features an
enamine functionality, which leaves a partial positive on the nitrogen as well as a partial negative
on the C(3) position via resonance contributors.
3.4.2

Isoindole
3.4.2a. Neutral tautomers
Isoindole derivatives have been used in dyes.12 for many years, yet it has remained

difficult to synthesize isoindoles that do not carry a substituent on the nitrogen atom.13 Isoindole
is far less stable than its indole counter-part, in part due to its lack of resonance contributors and
incomplete benzenoid unit.14 Because of this, we propose a semi-stable neutral tautomer of
isoindole, 3C-Iso. Accordingly, DFT calculations were performed, the results of which are listed
in Table 3.2, that show a 29% tautomeric contribution of 3C-Iso in vacuum conditions.
Conversely, in aqueous solutions 3C-Iso would be the predominant tautomer with only 11% in
population from 2H-Iso. It is understandable to find that the non-conjugated 3C-Iso tautomer is
more stable, simply because of its complete benzenoid unit.
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Figure 3.4. Neutral tautomers for isoindole as found in vacuum.
Joule14 stated tautomeric rearrangements can occur due to solute-solvent effects.
In this case, it has been shown that aprotic solvents favor 2H-Iso, which correlates with the
vacuum calculations, while protic solvents have been shown to favor imine arrangements, such
as the 3C-Iso neutral tautomer. If a protic solvent were to be placed around the 2H-Iso tautomer
a large solvent cage would result inhibiting the accessibility to or the release of the proton. To
mimic the experimental results the two tautomers were run under the same parameters using the
SM8 solvent model where dimethyl sulfoxide (DMSO) was used as the solvent. This polar
aprotic solvent favored the 2H-Iso arrangement.
The different tautomeric stabilities are also evident in the molecular electrostatic potential
maps as shown in Figure 3.5. The more evenly distributed electrostatic charges indicate a higher
difficulty of solvation. In other words the interactions between the polar aqueous solvent and the
tautomer would not be as stable as a non-uniform molecular electrostatic potential map, as
shown in Figure 3.5b.
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a)

b)

Figure 3.5 Molecular electrostatic potential maps of the a) 3C-Iso and b) 2H-Iso tautomers of
isoindole.
The solvation energies correspond to the rearrangements from the most stable gas phase
neutral tautomer (or aprotic solvent) to the most stable aqueous phase neutral tautomer. These
are listed in Table 3.2. As previously mentioned the solvation energy is the adjustment energy
from being solvated, it can also be used in this case as the adjustment energy from being in a
non-hydrogen bonding environment to one that is.
Table 3.2 Relative energies and solvation energies of the neutral and cationic tautomers for
indole.

Compound

ΔEvac (kJ mol-1)

Esolv (kJ mol-1)

ΔEH2O (kJ mol-1)

Isoindole –Neutral
2H-Iso

0.00

-21.5

5.46

3C-Iso

3.26

-30.5

0.00

Isoindole Cations
3C-Iso+

0.00

-233.

0.00

2H-Iso+

178.

-253.

159.
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3.4.2b. Cationic tautomers
One stable form of protonated isoindole was predicted using the calculations described.
The relative energies listed in Table 3.2 correspond to the tautomers shown in Figure 3.6. In the
two neutral tautomers, only 3C-Iso would become ionized to a protonated state, 3C-Iso+. In
chapter two it was shown that protonated imines lie lower in energy than protonated amines.
Again this has to do with the stabilizing effect of retaining hybridization on the basic atom.

Figure 3.6. Cationic tautomers for isoindole as found using a water solvent model, SM8.
Adding to this, 3C-Iso+ also has a complete benzenoid unit, which results in 3C-Iso+
being far more stable than 2H-Iso+. The scheme for isoindole acting as a carbon acid is shown
in Figure 3.7. This is proposed to occur in both vacuum and solution.

Figure 3.7. Dissociation scheme for isoindole in vacuum acting as a carbon acid.
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3.4.3

Indazole

Table 3.3. Relative energies and solvation energies of the neutral and cationic tautomers for
indazole.
Compound

ΔEvac (kJ mol-1)

Esolv (kJ mol-1)

ΔEH2O (kJ mol-1)

Indazole – Neutral
1H-Ind

0.00

-23.7

0.00

2H-Ind

20.1

-30.0

13.7

3C-Ind

80.6

-32.4

71.9

7aC-Ind

219.

-34.8

208.

Indazole Cations
1Hm-Ind+

0.00

-237.

0.00

3Cm-Ind+

69.3

-235.

72.3

3Co-Ind+

91.1

-240.

88.4

1Ho-Ind+

91.2

-246.

82.3

2Hm-Ind+

171.

-253.

155.

3.4.3a. Neutral tautomers
Indazole rarely exists in nature and when it is found it is usually substituted.15 Much like
isoindole, a common tautomer of indazole, 2H-Ind, contains an unstable, incomplete benzenoid
unit. 1H-Ind can be presumed to be the most stable tautomer because both rings are involved in
the overall resonance. An NMR16 spectrum (1H) shows all peaks to have a shift greater than 6
ppm, indicating all atoms are involved in aromaticity. 1H-Ind has been correlated
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experimentally to be the most stable neutral tautomer in solution and the gas phase through
microwave and ultra-violet spectroscopy.17-20

In addition, two other rare tautomers were explored for the purpose of this report. The
first rare tautomer, 3C-Ind, was shown to be the third most stable tautomer in vacuum and
solution. This can easily be explained though lack of conjugation in the pyrazole ring. The other
rare tautomer, 7aC-Ind, has an incomplete benzenoid unit, incomplete conjugation, and nonplanarity, which has a dihedral angle of 141.87 °. This yielded a tautomer that was found to be
statistically improbable.

Figure 3.8. Neutral tautomers for indazole as found in vacuum.
3.4.3b. Cationic tautomers
It is not difficult to understand the results from the cationic tautomers listed in Table 3.3.
1Hm-Ind+ retains the conjugated and hybridized stability of the compound while being
protonated. Furthermore, the compound does not adopt a quinoid feature, which is generally less
stable than a benzenoid feature. Previous infra-red gas phase21 studies on protonated indazole
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concluded that 1Hm-Ind+ was the only probable tautomeric form of cationic indazole. The same
group also performed theoretical calculations in which they found approximately a 100 kJ mol-1
energy difference between 1Hm-Ind+ and the next most stable tautomer, 3Cm-Ind+.

Figure 3.9. Cationic tautomers for indazole as found in vacuum.
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3.4.4. Benzimidazole
Table 3.4. Relative energies and solvation energies of the neutral and cationic tautomers for
benzimidazole.
Compound

ΔEvac (kJ mol-1)

Esolv (kJ mol-1)

ΔEH2O (kJ mol-1)

Benzimidazole –Neutral
1H-B

0.00

-37.6

0.00

2C-B

130.

-51.3

116.

Benzimidazole Cations
1Himine-B+

0.00

-244.

0.00

2C-B+

154.

-253.

145.

1Hamine-B+

178.

-275.

147.

3.4.4a. Neutral Tautomers
It has been a theme throughout the tautomeric stabilities of the indole related compounds that
structures that contain quinoid or an incomplete benzenoid unit tend to be less stable. This
observation is again on display with the tautomeric forms of benzimidazole.

Figure 3.10. Neutral tautomers for benzimidazole as found in vacuum.
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3.4.4b. Cationic tautomers
1Himine-B+ was found to be the most stable cationic tautomer for benzimidazole due to the
stability it retains following protonation. This cationic tautomer, unlike the others, maintains sp2
hybridization in both rings and follows Hückel’s rule. There were two other possible cationic
tautomers explored, which were found to be statistically improbable. Anderson22 and colleagues
used polarized two-photon excitation spectra of benzimidazole and its cation and found the same
structure for the neutral and cationic state of benzimidazole. The associated energies for all
cationic tautomers are listed in Table 3.4 and their structures can be seen in Figure 3.11.

Figure 3.11. Cationic tautomers for benzimidazole as found using a water solvent model, SM8.
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3.4.5. 7-Azaindole
Table 3.5. Relative energies and salvation energies of the neutral and cationic tautomers for 7azaindole.
Compound

ΔEvac (kJ mol-1)

Esolv (kJ mol-1)

ΔEH2O (kJ mol-1)

7-Azaindole – Neutral
1H-A

0.00

-30.4

0.00

3C-A

59.9

-28.7

43.5

7-Azaindole Cations
1Himine-A+

0.00

-232.

0.00

7H,3C-A+

45.8

-241.

37.0

1H,3C-A+

74.3

-261.

45.5

1Hamine-A+

130.

-259.

103.

3.4.5a. Neutral Tautomers
7-Azaindole is a widely used compound. Its skeleton has been incorporated into
pharmaceutical structures,23 coordination chemistry,24,25 and used to tune photochromic
compounds.26 The compound is fully aromatic with ten π-electrons in the most stable tautomer
(1H-A). 7-Azaindole can form two plausible tautomers where the unstable tautomer (3C-A)
would be considered rare in gas phase or solution. The calculated relative energies can be seen
in Table 3.5.
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Figure 3.12. Neutral tautomers for 7-azaindole as found in vacuum.
3.4.5b. Cationic Tautomers
The relative stabilities for the cationic tautomers of 7-azaindole are listed in Table 3.5.
The results are as expected where the protonation occurs on the imine nitrogen of 1H-A. The
rare tautomer results can be explained just as the aforementioned compounds have. First,
7H,3C-A+ shows a greater stability than 1H,3C-A+ because the charge is delocalized over the
six-member ring. Secondly, the hybridization of the pyrrole nitrogen in 1Hamine-A+ is
compromised revealing a great loss in stability and large relative energy difference.

Figure 3.13. Cationic tautomers for azaindole as found in vacuum.
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3.4.6. Caffeine
3.4.6a. Neutral Species
Caffeine is one of the most popular compounds in the world. Not only is it widely used
in chemistry, it is commonly discussed in the general public. Caffeine is also the most consumed
stimulant in the world.27 It is a trimethylated xanthine that acts on the central nervous system to
replace adenosine on the receptors of nerve cells.28 When caffeine is degraded in the liver the
following three compounds are found in decreasing concentrations: paraxanthine (1,7-dimethyl),
theobromine (3,7-dimethyl), and theophylline (1,3-dimethyl).29

Figure 3.14. The singular, neutral tautomer of caffeine. The numbering scheme is different
from indole derivatives as noted above.
3.4.6b. Cationic Species
The protonated form of caffeine has been known and understood for many years.30-32
The protonation takes place on the N(9) position resulting in a protonated imine as determined
theoretically and experimentally.
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Figure 3.15. The cationic tautomer of caffeine.
3.4.6c. Anionic Species
Caffeine exists in only one tautomeric form which has the capability to lose a proton only
at the C(8) position as determined theoretically.

Figure 3.16. Dissociation of caffeine to its anionic form.
The anionic dissociation was puzzling for this compound. The dissociation constant, at
standard conditions, is 14.33-35 While this may not seem unusual at first, it is quite bewildering.
In order to obtain a dissociation constant where the neutral species dissociates to produce an
anion the C(8) proton would have to abstracted. The issue our group takes is not on carbon
acids, but the probability of a carbon acid having a low dissociation constant with no major
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electron withdrawing groups or resonance stabilization. In fact, the two nitrogen atoms on the
five-member ring should donate electron density through resonance. Simply due to the fact that
there are no other protons to dissociate, caffeine would need to act like a carbon acid. However,
we assert that the dissociation constant published may be incorrect and the numerical value has
been reproduced many times over without a re-examination on the experimental techniques.
Quantum descriptors were examined to assist in correlating the dissociation of the sp2 CH
proton.

At times the natural charges can be used in predicting an outcome for the dissociation

patterns. In this case the charges for N(7), C(8), H(10), and N(9) were -0.361, 0.241, 0.264, and
-0.546, respectively. Since the dissociation site holds charges of the same sign one would predict
there to be repulsion between the carbon and hydrogen, however many indole and purine
compounds (known nitrogen acids) have this motif. Therefore, it was concluded that the natural
charges no longer applied as a model for predicting the behavior on this compound.
The energy change under the solvent model can act as an excellent surrogate in predicting
how a compound will dissociate. An example compound can be examined to assist in the
understanding of the dissociation of caffeine. Benzimidazole has been shown to act as a nitrogen
acid. The energy change from the neutral species to the anionic species in water is 1213 kJ mol1

. This correlates to most other N-heterocyclic nitrogen acids. However, under the

computational methods described above if benzimidazole were to be a carbon acid, losing a
proton from the C(2) position, the energy change in water would be 1367 kJ mol-1. The findings
were similar to caffeine where the energy change was 1365 kJ mol-1. This corresponds to
caffeine acting as a carbon acid, but this should be followed up by further experimental data.
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3.5 Conclusion:
The neutral and cationic tautomers of five indole related compounds along with caffeine
were evaluated for their relative stabilities. From this study one can assume that most Nheterocycles will lose a proton from the nitrogen. Surprisingly, certain compounds studied were
shown to act as carbon acids. This is especially true if the nitrogen atom were to undergo a
hybridization change. This anomaly leads to bond rearrangements for the cationic formation of
indole, isoindole, and the anionic formation of caffeine. This was interesting to uncover due to
the unexpected outcome and the implications it has on the wide array of systems these
compounds are involved in.
3.6 References
1

Shevyrin, V.; Melkozerov, V.; Nevero, A.; Etsov, O.; Baranovsky, A.; Shafran, Y. Synthetic

Cannabinoids as Designer Drugs: New Representatives of Indol-3-Carboxylates as a Novel
Group of Cannabinoids. Forensic Sci Intl, 2014, 244, 263-275.
2

Beck, J.; Ineman, J. M.; Rowan, S. J. Metal/Ligand-Induced Formation of Metallo-

Supramolecular Polymers. Macromolecules, 2005, 38, 5060-5068.
3

Inamoto, K.; Katsuno, M.; Yoshino, T.; Arai, Y.l Hiroya, K.; Sakamoto, T. Synthesis of 3-

Substituted Indazoles and Benzoisoxazoles via Pd-Catalyzed Cyclization Reactions: Application
to the Synthesis of Nigellicine. Tetrahedron, 2007, 63, 2695-2711.
4

Lee, J.-H.; Lee, J. Indole as an Intercellular Signal in Microbial Communities. FEMS

Micribiol Rev, 2010, 34, 426-444
5

Rocha, G. B.; Freire, R. O.; Simas, A.; Stewart, J. J. P. J. Comput. Chem. 2006, 27, 1101.

6

Becke, A. D. J. Chem. Phys., 1993, 98, 5648-5652.

7

Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B, 1998, 37, 785-789.

8

Marenich, A. V.; Olson, R. M.; Kelly, C. P.; Cramer, C. J.; Truhlar, D. G. J. Chem. Theory

Comput., 2007, 3, 2011.
66

9

Hess, B. A.; Schaad, L. J.; Holyoke, C. W. Tetrahedron, 1972, 28, 3657.

10

Sundberg, R. J. Indoles Academic Press, Inc. San Diego, 1996.

11

Alata, I.; Bert, J.; Broquier, M.; Dedonder, C.; Feraud, G.; Grégoire, G.; Soorkia, S.; Marceca,

E.; Jouvet, C. Electronic Spectra of the Protonated Indole Chromophore in the Gas Phase. J.
Phys. Chem. A, 2013, 117, 4420-4427.
12

Alberto, M. E.; De Simone, B. C.; Mazzone, G.; Quartarolo, A. D.; Russo, N. Theoretical

Determination of Electronic Spectra and Intersystem Spin-Orbit Coupling: The Case of
Isoindole-BODIPY Dyes. J. Chem. Theory Comput., 2014, 10, 4006-4013.
13

Bonnett, R.; Brown, R. F. C. Isoindole. J. C. S. Chem. Comm., 1972, 7, 393-395.

14

Joule, J. A.; Mills, K. Heterocyclic Chemistry, 4th Ed; Wiley&Sons: West Sussex, UK, 2000.

15

Atta-ur-Rahman; Malik, S.; Cun-heng, H; Clardy, J. Tetrahedron Lett., 1995, 36, 2759-2762.

16

Indazole: http://sdbs.db.aist.go.jp (National Institute of Advanced Industrial Science and

Technology, 10/26/2015).
17

Elguero, J.; Marzin, C.; Katritzky, A. R.; Linda, P. The Tautomerism of Heterocycles,

Academic Press, New York, 1976.
18

Elguero, J. Pyrazoles and Their Benzo Derivatives, in Comprehensive Heterocyclic

Chemistry, Pergamon Press, Oxford, 1984, pp 291-297.
19

Velino, B.; Cané, E.; Trombetti, A. Microwave Spectrum and ab Initio Calculations of

Indazole. J. Molec. Spec., 1992, 155, 1-10.
20

Catalán, J.; de Paz, J. L. G.; Elguero, J. Importance of Aromaticity on the Relative Stabilities

of Indazole Annular Tautomers: an ab Initio Study. J. Chem. Soc., Perkin Trans. 2, 1996, 5760.
21

Oomens, J.; Meijer, G.; von Helden, G. An Infrared Spectroscopic Study of Protonated and

Cationic Indazole. Int. J. Mass. Spec., 2006, 249/250, 199-205.
22

Anderson, B. E.; Jones, R. D.; Rehms, A. A.; Ilich, P.; Callis, P. R. Polarized Two-Photon

Fluorescence Excitation Spectra of Indole and Benzimidazole. Chem. Phys. Lett., 1986, 125,
106-112.
23

Bryan, M. C.; Falsey, J. R.; Frohn, M.; Reichelt, A.; Yao, G.; Bartberger, M. D.; Bailis, J. M.;

Zalameda, L.; San Miguel, T.; Doherty, E. M.; Allen, J. G. N-substituted Azaindoles, as Potent
Inhibitors of Cdc7 Kinase. Bioorg. Med. Chem. Lett., 2013, 23, 2056-2060.

67

24

Koyama, T.; Wakisaka, A. Molecular Self-Assembly Composed of Aromatic Hydrogen-Bond

Donor-Acceptor Complexes. J Chem. Soc., Faraday Trans., 1997, 21, 3813-3817.
25

Dufour, N.; Dartiguenave, Y.; Dartiguenave, M.;Lebuis, A.-M.; Bélanger-Gariépy, F.;

Beauchamp, A. Crystal Structures of 7-Azaindole, an Unusual Hydrogen-Bonded Tetramer, and
of Two of its Methylmercury(II) Complexes. Can. J. Chem., 1990, 68, 193-201.
26

Sun, Z.; Li, H.; Liu, G.; Fan, C.; Pu, S. Photochromisn of New Unsymmetrical Diarylethenes

Based on the Hybrid of Azaindole and Thiophene Moieties. Dyes and Pigments, 2014, 106, 94104.
27

Daly, J. W.; Holmén, J.; Fredholm, B. B. Is Caffeine Addictive? The most Wodely Used

Psychoactive Substance in the World Affects the Same Parts of the Brain as Cocaine.
Lakartidningen, 1998, 95, 5878-5883.
28

Fisone, G.; Borgkvist, A.; Usiello, A. Caffeine as a Psychomotor Stimulant: Mechanism of

Action. Cellular and Molecular Life Sciences, 2014, 61, 857-872.
29

Martínez-López, S.; Sarriá, B.; Baeza, G.; Mateos, R.; Bravo-Clemente, L. Pharmacokinetics

of Caffeine and its Metabolites in Plasma and Urine After Consuming a Green/Roasted Blend by
Healthy Individuals. Food Research International, 2014, 64, 125-133.
30

Sondheimer, E.; Covitz, F.; Marquisee, M. J. Association of Naturally Occurring Compounds,

the Chlorogenic Acid-Caffeine Complex. Arch. Bioch. Biophys., 1961, 93, 63-71.
31

Marta, R. A.; Wu, R.; Eldridge, K. R.; Martens, J. K.; McMahon, T. B. Infrared Vibrational

Spectra as a Structural Probe of Gaseous Ions Formed by Caffeine and Theophylline. Phys.
Chem. Chem. Phys., 2010, 12, 3431-3442.
32

Bahrami, H.; Tabrizchi, M.; Farrokhpour, H. Protonation of Caffeine: A Theoretical and

Experimental Study. Chemical Physics, 2013, 415, 222-227.
33

Dean, J.A. Lange’s Handbook of Chemistry, 13th Ed; McGraw-Hill: New York, 1985.

34

Perera, V.; Gross, A. S.; McLachlan, A. J. Measurement of CYP1A2 Activity: A Focus on

Caffeine as a Probe. Current Drug Metabolism, 2012, 13, 667.678.
35

Marra, M. C.; Silva, P. L.; Muñoz, R. A. A.; Richter, E. M. Ultra-Fast Determination of

Scopolamine, Orphenadrine, Mepyramine, Caffeine, Dipyrone, and Ascorbic Acid by Capillary
Electrophoresis with Capacitively Coupled Contactless Conductivity Detection. J. Braz. Chem.
Soc., 2014, 25, 913-919.

68

CHAPTER FOUR
Computational Estimation of the pKa’s of Purine and Purine Related Compounds

4.1 Abstract:
Quantitative structure-activity relationships provide powerful insight for physical
properties that have not been determined experimentally. The acid dissociation constant, pKa, is
especially useful because it allows for one to know the ionic form a compound may take in
different environments. Thirty-one purine and related compounds were examined using quantum
chemical calculations to estimate the acid dissociation constant for those which were not readily
available. Various descriptors were used to evaluate linear free energy relationships and a
multivariable linear free energy relationship.
4.2 Introduction:
The acid dissociation value pKa of a compound provides important information regarding
the neutral and ionic forms of the compound present under different conditions. However, for
many compounds experimental pKa values are not available, and some others the measured
values may be uncertain. Consequently, having a computational means for estimating pKa
values can be beneficial for biochemical, pharmaceutical, polymer, and many other studies.
The acid dissociation constant can be derived through the following generic chemical
reaction:
[1]
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where the equilibrium constant, Ka, is a ratio of the product activities to the reactant activity.
More frequently, concentrations are used in place of activities as approximations for practical
purposes. The pKa of the acid is then described by a logarithmic relationship to Ka.
[2]
In principle, a thermodynamic relationship can then be obtained using the previous equation:
[3]
where ΔGo is the standard Gibbs energy change for the dissociation, R is the ideal gas constant, T
is the absolute temperature in kelvins. For the purposes of the present research the temperature
is assumed to be 298.15 K. Thus there is a direct linear relationship between the Gibbs energy
change and the pKa.1
There are many theoretical approaches to estimate the pKa of a compound. One such
route is through first principles. This involves a purist methodology that does not rely on any
previous experimental values.2 However, this approach is computationally demanding and
requires high levels of accuracy. The absolute technique requires calculation of the Gibbs
energy change to within 5.69 kJ mol-1 in order to obtain solution pKa values to within one pKa
unit.3,4 Another method commonly used in commercial programs is a fragment based approach
that uses empirical values to theoretically derive pKa’s. Groups of starting compounds are
‘fragmented’ and Hammett constants are applied. In this way a theoretical pKa is derived by
giving more or less weight to each fragment depending on its relevance to the parent compound.
A weakness of this methodology is that it requires suitable pre-programmed fragments. The
final methodology is a quantitative structure-activity relationship (QSAR).
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QSAR’s are centrally focused on finding a mathematical relationship between one or
more molecular features and a specific molecular behavior.2 The mathematical relationship
takes on the form:
[4]
In this expression Pj is a molecular property of interest, the Xi’s are molecular descriptors, and
the ci’s are the coefficients of these descriptors. The QSAR technique first employs a literature
search to gather published data on the desired physical property for different compounds.
Quantum chemical (QC) calculations are performed to derive descriptors that yield ‘clues’ to the
compound’s behavior. It is assumed that each descriptor adds a characteristic Gibbs energy
change, ΔGi0 to the property of interest. Accordingly, expression [4] is sometimes called a linear
free energy relationship (LFER).2
4.3 Computational Methods:
We have developed a QSAR approach for estimating the pKas of purines and related
compounds. A group of thirty-one compounds was first assembled to find literature values for
their dissociation constants. These compounds have two dissociation constants which we will
call pKa1 and pKa2:
cation  neutral form
pKa1

neutral form  anion
pKa2

The collected literature values can be found in Table 4.1, which also contains computational
values obtained using Advanced Chemical Development’s (ACD) Percepta Phys Chem Suite
commercial program. The dissociation constants were recorded at 25°C and in aqueous solution.
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Along with the solution pKa values, vapor phase Gibbs energy changes for deprotonation
reactions of some of these compounds have been experimentally determined and can be found on
the National Institute of Standards and Technology’s (NIST) ChemwebBook website.5
As previously described in Chapters 2 and 3, these compounds can exist in a variety of
tautomeric forms. For the present study, only the most stable tautomeric forms of each
compound were considered. The most stable neutral tautomers of each compound were first
built and then examined using the semi-empirical quantum chemical method RM1.6 This was
followed by an ab initio analysis using density functional theory with the B3LYP functional of
Becke,7 Lee, Yang, and Parr8 and the basis set 6-31+G**, i.e. at the B3LYP/6-31+G** level.
Each compound was optimized in vacuum followed by a calculation applying the water solvent
model, SM8 of Marenich et al.9 Having obtained the neutral forms the associated possible cation
and anionic forms were determined and calculated in the same manner as above. Quantum
chemical descriptors for each of the compounds were determined and analyzed. These included
N-H bond lengths, RNH, the energy differences between the highest occupied molecular orbital
(HOMO) and the lowest unoccupied molecular orbital (LUMO), ΔεHL, relevant atomic charges,
Qi, bond orders, BOi, energy differences between the parent compound and the product species,
ΔEi, etc. Tables were compiled from these calculations. Mathematical relationships were sought
of the form:
pKa =

.

[5]

Various statistics were recorded when examining the QSAR models. The statistics allow
one to identify the best correlations between pKa’s and the descriptors, the uncertainties
associated with each descriptor, and other statistical measures. It is also important that outliers—

72

compounds falling outside the regression models-- be examined. These can be insightful
because they may shed light on shortcomings of either the model or the experimental values.2
Table 4.1. Experimental pKa values for purine and related compounds along with theoretical values
obtained from ACD/Phys Chem Suite.

Compound

Formula

pKa1

pKa2

ACD pKa1

ACD pKa2

1

Adenine

C5H5N5

4.210,11

9.810, 11

4.4±0.1

9.9±0.1

2

4-Azaindole

C7H6N2

6.912

6.9±0.1

14.7±0.3

3

5-Azaindole

C7H6N2

8.312

8.2±0.3

15.2±0.3

4

6-Azaindole

C7H6N2

7.912

7.8±0.1

14.7±0.3

5

7-Azaindole

C7H6N2

4.612

4.9±0.1

13.9±0.3

6

Benzimidazole

C7H6N2

5.310, 5.511, 13,14

12.011,
5.3±0.1
10
13
12.3 ,12.8 ,
12.914

12.6±0.1

7

Benzimidazoline

C7H8N2

8

Carbazole

C12H9N

9

Caffeine

C8H10N4O2 0.516

6.9±0.2
-4.915

17.115

-2.4±0.5

14.017

0.5±0.7

17.0±0.3

10 Diphenylamine

C12H11N

0.911,18

0.8±0.2

11 Guanine

C5H5N5O

3.311, 19

9.211,19,
3.4±0.3
11
19
12.3 , 12.4

9.6±0.2

12 Hypoxanthine

C5H4N4O

1.1910, 2.2020,

8.810, 12.010

2.2±0.3

8.9±0.5

13 Indazole

C7H6N2

1.315

13.915

1.3±0.1

14.0±0.1

14 Indole

C8H7N

-3.614

16.9710

-2.4±0.5

17.0±0.3

15 Indoline

C8H9N

4.914

16 Isatin

C8H5NO2

5.2±0.2
-1.9±0.2

10.3±0.2
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17 Isoguanine

C5H5N5O

18 Isoindole

C8H7N

19 Oxindole

C8H7NO

20 Paraxanthine

C7H9N4O2

21 Phthalimide

C8H5NO2

22 Purine

C5H4N4

23 6-Mercaptopurine

4.518

9.018

3.7±0.2

10.8±0.4

0.9±0.2

14.8±0.2

8.623

0.2±0.7

8.5±0.7

9.911

-5.2±0.2

10.4±0.2

8.910,11

2.7±0.1

9.2±0.1

C5H4N4S

7.7721

2.3±0.2

10.9±0.2

24 Saccharin

C7H5NO3S

2.311

-12.8±0.2

1.6±0.1

25 Skatole

C9H9N

16.610

-1.6±0.5

17.3±0.3

26 Theobromine

C7H8N4O2

7.911, 8.816

0.4±0.7

9.9±0.7

27 Theophylline

C7H8N4O2

8.619

1.8±0.7

8.6±0.5

28 Uric Acid

C5H4N4O3

5.610, 5.511

-1.9±0.2

5.6±0.3

29 9-Methyluric Acid

C6H6N4O3

5.722

-1.9±0.2

5.6±0.3

30 Xanthine

C5H4N4O2

0.818

7.5310

1.0±0.7

7.6±0.5,
13.9±0.2

31 9-Methylxanthine

C6H6N4O2

2.022

6.311,
10.522,23

0.1±0.7

6.3±0.7

2.511

0.6811

4.4 Results and Discussion:
An initial step in evaluating the results is to verify that in the absence of a solvent the
level of approach (functional and basis set) is adequate for the dissociation reaction in the
absence of a solvent. This was examined using Gibbs energy changes for deprotonation reactions
found on the NIST webpage (http://webbook.nist.gov) and comparing with the corresponding
values determined at the B3LYP/6-31+G** level. The Gibbs energy change for the dissociation
can be found using the following generic equations based on expression [1].

74

[6]
A few things should be noted regarding the calculations and plot. First, the Gibbs energy could
not be calculated within the solvent due to coding limitations of the Spartan ’10 program, and
therefore all values apply to vacuum conditions. Second, the Gibbs energy Go of a proton was
determined to be ~ -26.3 kJ mol-1. The derivation for this can be found in the appendix. The
values used in the Gibbs energy plot can be seen in Table 4.2. It should be noted the calculated
values all fell within the experimental uncertainties.
Table 4.2 Experimental and calculated Gibbs energy changes used in Figure 4.1.
Compound

ΔGrxn NIST (kJ mol-1) ΔGrxn Calc. (kJ mol-1)

Adenine

1372.

1382.

Indazole

1425.

1425.

Indole

1431.

1432.

Carbazole

1412.

1413.

Diphenylamine 1438.

1435.
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ΔGexp vs ΔGcalc
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Figure 4.1. Comparison of the experimental and calculated Gibbs energy changes for
dissociation of the neutral species to the anionic form and H+.
There were five experimental values in the NIST database that corresponded to the
present study. They were adenine, indole, indazole, carbazole, and diphenylamine. The resulting
comparison between experimental and calculated values is summarized in the following
expression:
ΔGexp = 1.199±0.043 ΔGcalc – 284.1±60.5 kJ mol-1

[7]

n = 5, R2 = 0.996, s = 1.86, F = 789.
The excellent regression statistics above show that the level of theory used, in the vacuum
model, is sufficient for accurate results. This is evident in the high R2 value, the large Fisher
statistic, and the high T-test value (28.9) of the slope.
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Because it is not possible to calculate Go within a solvent model we would like to find a
surrogate QC descriptor for the pKa regression calculations. The energy change ΔE has been
used in earlier studies and would seem to be a reasonable candidate.24,25 The experimental and
calculated values applied to this model can be seen in Table 4.3.
Table 4.3 The experimental Gibbs energies correlated with the calculated ΔEVAC.
Compound

ΔGrxn NIST (kJ mol-1) ΔGrxn Calc. (kJ mol-1)

Adenine

1372.

1439

Indazole

1425.

1489.

Indole

1431.

1496.

Carbazole

1412.

1476.

Diphenylamine 1438.

1501.

Accordingly the correspondence between ΔEVAC and ΔGexp was examined with the results shown
in Figure 4.2 and below:
ΔGexp = 1.047±0.019 ΔEVAC - 134.9±28.3 kJ mol-1

[8]

n = 5, R2 = 0.999, s = 0.956, F = 2295.
Ironically, the statistics provided in expression [8] were better than those in expression [7]. This
encourages the suggestion that ΔE might act as a good regression descriptor, because of the
relationship
.

[9]
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Figure 4.2. A plot of ΔEvac against the experimental (NIST) Gibbs energies.
Following this it was desirable to test the ΔE descriptor’s ability to model the aqueous
pKa values. A first test was to see if the ΔEVAC is sufficient for modeling these pKa’s. In other
words, do the calculations need to be taken to the additional step of applying the SM8 solvent
model? This was tested using pKa1.
Four compounds were removed from this regression calculation (indole, indoline, 7azaindole, and diphenylamine) because they were considered to be outliers. (See further
explanation below.) As seen, ΔEVAC performs surprisingly well. Figure 4.3 and the regression
statistics below suggest that there is considerable correlation without using the solvent model.
pKa1 = 0.0824±0.0104 ΔEVAC – 77.12±10.12

[10]

n = 15, R2 = 0.8285, s = 1.46, F = 62.8
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Figure 4.3. The QSAR plot for experimental pKa2 against the QC descriptor ΔEVAC.
The experimentally determined dissociation constants were measured in aqueous
solutions. The ΔEVAC descriptor does not take into account potential solvent-solute interactions.
The next test was to apply the solvent model to see if that led to a better correlation. The results
for pKa1 are shown below and in Figure 4.4.
pKa1 = 0.1042±0.0070 ΔEVAC – 119.92±8.24

[11]

n = 15, R2 = 0.9445, s = 0.828, F = 221.
The statistics from expression [11] indicate that the addition of a solvent model assists the
regression calculations. In this case the coefficient of determination, R2, increases. This
indicates that there was a 94% correlation between the experimental values and our model. Of
the original thirty-one compounds nineteen had experimental pKa1 values reported. Four
compounds were regarded as outliers and removed from the regression calculations. The
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compounds removed were 7-azaindole, indole, indoline, and diphenylamine. Indole act as
carbon acids and thus fall outside the nitrogen acid scheme. (Indole was discussed in chapter
three.) Indoline is an aniline derivative—no other compound is similar to this in the set and
therefore indoline is an outlier.
7-Azaindole is known to dimerize in solution due to bimolecular hydrogen bonding. This
is shown below in Figure 4.4.

Figure 4.4. The bimolecular hydrogen bonding of 7-azaindole, which results in dimerization.
The phenomenon has been observed experimentally many times.26-28 In fact, Koyama et al.26
suggested that 7-azaindole will not be found as a singular unit unless forced through extreme
high or low temperatures. Therefore, our model was not suitable for this compound.
Diphenylamine was also considered an outlier. Surprisingly though, it correlated into our Gibbs
energy plots well. It is proposed that when compared directly with 31 compounds, it fell outside
of the scope of our data set because it was the only non-planar ring system.
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Figure 4.5. The QSAR plot for experimental pKa1 against the QC descriptor ΔEH2O.
For the compounds presented in this study each can undergo multiple dissociations. Thus
far the only experimental dissociation values examined are for pKa1. However, the loss of a
proton that forms an anionic compound needs to be evaluated, i.e. pKa2.
pKa2 = 0.131±0.009 ΔEH2O – 147.23 ±10.79

[12]

n = 18, R2 = 0.929, s = 1.17, F = 212.
Based on the regression calculations three compounds were eliminated from the original
data set. These compounds were caffeine, paraxanthine, and theobromine. Caffeine was
eliminated from the data set for acting like a carbon acid as discussed in chapter three. When the
experimental techniques were reviewed for paraxanthine and theobromine the determined pKa’s
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appeared correct. However, there seems to be some mechanism at play that is not mimicked in
our model. While there is not a clear cut answer at this point, it can be assumed that the
compounds may act similarly to caffeine because each of them is a caffeine metabolite.
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Figure 4.6. The QSAR plot for experimental pKa2 against the QC descriptor ΔEH2O.
A different QC descriptor was approached at this point. The change in the natural charge
on the nitrogen atom ΔQNH as it undergoes the dissociation is intuitively a reasonable descriptor.
This was correlated against the pKa2 values of each compound. As described in expression [12]
and Figure 4.6, caffeine, paraxanthine, and theobromine were eliminated from this data set.
pKa2 = 157.44±43.85 ΔQN-N(an.) – 3.302 ±1.983

[13]

n = 18, R2 = 0.4462, s = 3.27, F =12.9
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The regression calculations shown in expression [13] provide a coefficient of
determination that is far from great. However, there are obvious outliers that could be removed,
but were not for consistency with the other pKa2 regression calculations.
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Figure 4.7. The QSAR plot for experimental pKa2 against the QC descriptor ΔQNH.
At times, a QC descriptor may be mediocre in describing a physical property (as shown
in Figure 4.8). In spite of this, when an unreliable descriptor is combined with a high-impact
descriptor a successful multi-variant regression calculation may be acquired. This is displayed in
Figure 4.8 and expression [14] when the change in energy on the nitrogen atom for the neutral
species to its anionic form along with the change in energy with the solvent model is linearly
applied. As such, the following multi-variant LFER was formed using the QC descriptors: ΔQNH
and ΔEH2O for the pKa2.
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Figure 4.8. The QSAR plot for experimental pKa2 against the QC descriptors ΔEH2O and ΔQNH.
pKa2 = 0.1146±0.0070 ΔEH2O + 55.60±12.09 ΔQN-N(an.) – 129.86±8.11

[14]

n = 18, R2 = 0.971, s = 0.775, F = 250.
The success of expression [14] as shown in the statistics gives the opportunity to provide
estimation of the pKa2 for the compounds missing experimental values. This is also evident
when the calculated dissociation constants are compared to those derived through ACDPhysChem Suite. The values calculated using expressions [11], [12], and [14] are shown in
Table 4.2.

84

Table 4.4. Theoretically calculated pKa’s using the QSAR regressions shown in the figure 4.5,
4.6, and 4.8 above.
Compound

pKa1 [Eq. 11]

pKa2 [Eq. 12]

pKa2 [Eq.14]

4-Azaindole

----

14.5

15.2

5-Azaindole

----

14.6

14.9

6-Azaindole

----

16.0

15.9

7-Azaindole

----

14.8

15.2

Benzimidazoline

3.05

21.4

21.2

Diphenylamine

----

20.0

20.2

Indoline

----

24.5

24.4

Isatin

-11.2

10.3

10.9

Isoindole

-10.5

14.3

14.2

Oxindole

-8.87

13.5

14.0

Paraxanthine

0.47

----

----

Phthalimide

-12.7

----

----

6-Mercaptopurine

2.42

----

----

Saccharin

-14.0

----

----

Skatole

-4.78

----

----

Theophylline

0.86

----

----

Uric Acid

-10.4

----

----

9-Methyluric Acid

-10.0

----

----

Other QC descriptors were examined and failed to provide valuable plots. These
included the bond order and bond length. This is not atypical for QSAR plots using pKa’s as the
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physical property. This is because the bond order and bond lengths tend to stay within a small
range while the pKa values can be cover a wide range. A similar explanation can be used for the
change in energy from the HOMO to the LUMO.
4.5 Conclusion:
The ultimate goal for this study was to design a model allowing us to estimate the pKa’s
of purines and related compounds, with a secondary goal of estimating values for those
compounds in the collection that did not have experimental values found in the literature. This
was successfully performed using three different regression calculations on eighteen compounds.
As described in Chapter 1 purines and related compounds are used in a wide variety of
applications. For many purposes it is essential to have a known pKa value for each compound to
understand the form it will take in a given environment. The present study provides estimated
pKa values for eighteen compounds that were previously without experimental values. This can
provide insights that may be useful for some biochemical, pharmaceutical, and environmental
applications.
4.6 Appendix: Determination of the Gibbs energy Go for H+



Use the thermodynamic expression for enthalpy as the sum of the internal energy and the
product of pressure and volume.



Apply the ideal gas law where the number of moles is assumed to be one.



Express the internal energy Uo using the classical law of equipartition of energy for a
monatomic gas that has only translational energy.
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Substitute the internal energy and ideal gas law expressions into the enthalpy expression.



The Sakur-Tetrode equation, with M equals the molar mass in grams and T equals the
absolute temperature kelvins, leads to a value for the entropy of a monatomic gas of
molar mass = 1 g.



At T = 298.15 K this leads to the Gibbs energy of H+:
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